Where was this study done?
Study sites were in 15 countries.
Number of patients who received at least one dose of the
study medicines
Argentina 195
Australia 17
Canada 72
Germany 127
Italy 37
Japan 229
Republic of Korea 58
Netherlands 26
Poland 238
Romania 267
Russian Federation 640
South Africa 60
Spain 58
United Kingdom 13
United States 399
0 100 200 300 400 500 600 700
Number of patients
Which patients were included in this study?
Studies have a list of requirements for patients who can enrol (inclusion criteria) and
those who can’t (exclusion criteria). For this study, the main inclusion and exclusion
criteria are listed below.
Men and women were included in the study if they:
• Were at least 18 years old.
• Had been diagnosed with asthma at least one year before starting the
study.
• Were taking daily asthma treatment (medium to high dose of ICS, and
LABA) for at least 12 weeks before starting the study.
• Had poorly controlled asthma as scored using an asthma survey.